Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 6—June 2013
Letter

Clostridium difficile Infection Associated with Pig Farms

On This Page
Article Metrics
50
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Clostridium difficile of PCR ribotype 078 causes enteric disease in humans and pigs (1,2); a recent pan-European study revealed that this type was the third most frequently found type of C. difficile (1). The finding of identical C. difficile PCR ribotype 078 isolates in piglets with diarrhea and in humans with C. difficile infection (CDI) led to the suggestion that interspecies transmission might occur (3,4). Because C. difficile can be detected in the immediate environment of pig farms, we investigated intestinal colonization with C. difficile in pigs and in pig farmers, their relatives, and their employees in the Netherlands.

Persons living on 32 pig farms were enrolled as part of a longitudinal intervention study of several zoonotic agents. Pig farmers were partly recruited through the Dutch Farmer’s Association or by veterinarians, who informed potential participants about the aims of the study. Inclusion criteria for participants were that they should work and/or live on the farm; the farms were either closed farms or multipliers (farms at which piglets are bred and then sold to other farms, where they are raised until ready for slaughter). The number of persons willing to submit a fecal sample per farm ranged from 1 to 10 (mean 4, median 5). Veterinarians who normally provided veterinary services to each farm collected fresh fecal samples from the floors of 10 animal wards per farm. No a priori knowledge of C. difficile colonization status of the pigs on the farms was available. Fecal samples from humans and from animal wards were cultured for the presence of toxinogenic C. difficile by using previously described methods (1,3,4).

Of the 128 persons who enrolled in the study, 48 had daily contact with pigs, 22 had weekly contact with pigs, and 36 had contact with pigs varying from monthly to less than yearly; no contact information was available for 22 participants. A total of 12 (25%) of 48 persons who had daily contact with pigs had fecal samples positive for C. difficile colonization; for persons who had weekly contact with pigs, 3 (14%) of 22 had positive samples. Daily to weekly contact with pigs versus monthly to less than yearly contact was significantly associated with an intestinal presence of C. difficile (p = 0.003). C. difficile was also found in fecal samples from 3 persons for whom no contact information was available. The C. difficile carriage rate among those with daily to weekly contact with pigs (15/70, 21%) was higher than the carriage rate of <5% reported for nonhospitalized adults with CDI (5).

A total of 18 C. difficile–positive human samples were detected at 16 of 32 pig farms investigated. At 2 of these farms, only 1 person submitted a sample, but at the other 14 farms, the number of participants ranged from 2 to 9 (mean 4, median 3). C. difficile was found in pig manure at all farms; 10%–80% of the wards were positive per farm.

Corresponding C. difficile PCR ribotypes were cultured from samples from pigs and humans; type 078 was found in humans and pigs on 15 farms and type 045 in a farmer and his pigs on 1 farm. Multilocus variable number tandem repeat analysis (MLVA) and antimicrobial drug susceptibility testing (E-test) were performed on human isolates from 15 farms and 1 porcine isolate per farm. One human isolate could not be typed because the isolate was lost during laboratory activities.

MLVA results showed that, at 2 farms, the human and porcine isolates were not genetically related, whereas at the other 13 farms, human and porcine isolates were genetically related, including 100% identical MLVA results for type 078 human and porcine isolates at 3 farms. Isolates were considered genetically related when the summed tandem repeat differences were <10 (3,4,6).

Antimicrobial drug susceptibility testing demonstrated similar susceptibility levels among isolates. For human and porcine isolates from 9 of 15 farms, MIC variability of <1 μg/L was found for imipenem, cotrimoxazole, erythromycin, clindamycin, tetracycline, and moxifloxacin. For the remaining 6 farms, drug susceptibility patterns for human isolates differed from pig isolates for 1 drug only: for 1 farm, MICs of erythromycin were 256 μg/L for human isolates and 0.38 μg/L for pig isolates; for 3 farms, MICs of erythromycin were 256 μg/L for pig isolates and 0.25 μg/L for human isolates; and for 2 farms, MICs of imipenem were 32 μg/L for pig isolates and 1.5 or 2 μg/L for human isolates.

In summary, the high C. difficile carriage rate among persons who had direct contact with pigs and the fact that these C. difficile isolates were genotypically and phenotypically similar to the pig isolates from the same farms indicates that transmission occurs either by direct contact or through the environment. Prospective studies are needed to determine the relationship between C. difficile carriage and development of CDI in this population.

Top

Acknowledgment

This research was financially supported by ZonMW, the Netherlands organization for health research and development. None of the authors have any conflict of interest related to this article. This research is approved by the Animal Experiments Committee of Utrecht University and by the Medical Ethical Committee of Utrecht University.

Top

Elisabeth C. KeessenComments to Author , Céline Harmanus, Wietske Dohmen, Len J.A. Lipman, and Kuijper
Author affiliations: Utrecht University, Utrecht, the Netherlands (E.C. Keessen, W. Dohmen, L.J.A. Lipman); University Medical Center, Leiden, the Netherlands (C. Harmanus, E.J. Kuijper)

Top

References

  1. Bauer  MP, Notermans  DW, van Benthem  BH, Brazier  JS, Wilcox  MH, Rupnik  M, Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377:6373 . DOIPubMedGoogle Scholar
  2. Songer  JG, Anderson  MA. Clostridium difficile: an important pathogen of food animals. Anaerobe. 2006;12:14 . DOIPubMedGoogle Scholar
  3. Debast  SB, van Leengoed  LA, Goorhuis  A, Harmanus  C, Kuijper  EJ, Bergwerff  AA. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol. 2009;11:50511. DOIPubMedGoogle Scholar
  4. Goorhuis  A, Bakker  D, Corver  J, Debast  SB, Harmanus  C, Notermans  DW, Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008;47:116270 . DOIPubMedGoogle Scholar
  5. Loo  VG, Bourgault  AM, Poirier  L, Lamothe  F, Michaud  S, Turgeon  N, Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693703 . DOIPubMedGoogle Scholar
  6. Marsh  JW, O’Leary  MM, Shutt  KA, Pasculle  AW, Johnson  S, Gerding  DN, Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in hospitals. J Clin Microbiol. 2006;44:255866 . DOIPubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid1906.121645

Related Links

Top

Table of Contents – Volume 19, Number 6—June 2013

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Elisabeth C. Keessen, PO Box 80175, 3508 TD, Utrecht, The Netherlands

Send To

10000 character(s) remaining.

Top

Page created: May 07, 2013
Page updated: May 07, 2013
Page reviewed: May 07, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external